The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans
Abstract
PURPOSE OF REVIEW: This review details the independent effects of purified eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. We report data from the recent literature and our own controlled clinical trials which compared the independent effects of these fatty acids in individuals at increased risk of cardiovascular disease, namely overweight hyperlipidaemic men and treated-hypertensive, type 2 diabetic men and women. We discuss the biological effects of these fatty acids and the potential mechanisms through which they may affect cardiovascular disease risk factors. RECENT FINDINGS: A cardioprotective effect for omega3 fatty acids is supported by prospective studies demonstrating an inverse association between fish intake and coronary heart disease mortality. Data from secondary prevention trials support a reduction in ventricular fibrillation as a primary mechanism for the decreased incidence of myocardial infarction. Clinical trials and experimental studies have shown that omega3 fatty acids have many other potentially important antiatherogenic and antithrombotic effects. Omega-3 fatty acids lower blood pressure and heart rate, improve dyslipidaemia, reduce inflammation, and improve vascular and platelet function. These favourable effects have until recently been primarily attributed to the omega3 fatty acid eicosapentaenoic acid, which is present in large amounts in fish oil. Controlled studies in humans now demonstrate that docosahexaenoic acid, although often present in lower quantities, has equally important anti-arrhythmic, anti-thrombotic and anti-atherogenic effects. SUMMARY: Available evidence strongly suggests that eicosapentaenoic acid and docosahexaenoic acid have differing haemodynamic and anti-atherogenic properties. The effects of the two fatty acids may also differ depending on the target population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
Blood Levels of Long-Chain n–3 Fatty Acids and the Risk of Sudden Death
Albert, C. M., Campos, H., Stampfer, M. J., Ridker, P. M., Manson, J. E., Willett, W. C., & Ma, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012918 · Cited by 1,146
Fish and Omega-3 Fatty Acid Intake and Risk of Coronary Heart Disease in Women
Hu, F. B. (2002) · JAMA · doi:10.1001/jama.287.14.1815 · Cited by 1,018
Fish consumption and the 30-year risk of fatal myocardial infarction
Daviglus, M. L., Stamler, J., Orencia, A. J., Dyer, A. R., Liu, K., Greenland, P., Walsh, M. K., Morris, D., & Shekelle, R. B. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361502 · Cited by 902
Mori, T. A., Burke, V., Puddey, I. B., Watts, G. F., O’Neal, D. N., Best, J. D., & Beilin, L. J. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1085 · Cited by 588
Self-citationEffect of Fish Oil on Heart Rate in Humans: A Meta-Analysis of Randomized Controlled Trials
Mozaffarian, D., Geelen, A., Brouwer, I. A., Geleijnse, J. M., Zock, P. L., & Katan, M. B. (2005) · Circulation · doi:10.1161/circulationaha.105.556886 · Cited by 399
Woodman, R. J., Mori, T. A., Burke, V., Puddey, I. B., Watts, G. F., & Beilin, L. J. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.1007 · Cited by 338
Self-citationMori, T. A., Woodman, R. J., Burke, V., Puddey, I. B., Croft, K. D., & Beilin, L. J. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00407-6 · Cited by 322
Self-citationFish oil and glycemic control in diabetes. A meta-analysis.
Friedberg, C. E., Janssen, M. J. F. M., Heine, R. J., & Grobbee, D. E. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.494 · Cited by 303
Research works printed but not linked: 68
- Zhang, 1999, Fish consumption and mortality from all causes, ischemic heart disease, and stroke: an ecological study, Prev Med, 28, 520, 10.1006/pmed.1998.0472 · DOI · Paper page
- Marckmann, 1999, Fish consumption and coronary heart disease mortality. A systematic review of prospective cohort studies, Eur J Clin Nutr, 53, 585, 10.1038/sj.ejcn.1600832 · DOI · Paper page
- Leaf, 1996, Prevention of cardiac sudden death by N-3 fatty acids: a review of the evidence, J Intern Med, 240, 5, 10.1046/j.1365-2796.1996.449803000.x · DOI
- Harris, 1997, n-3 fatty acids and serum lipoproteins: human studies, Am J Clin Nutr, 65, 1645S, 10.1093/ajcn/65.5.1645S · DOI · Paper page
- Bao, 1998, Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives, Hypertension, 32, 710, 10.1161/01.HYP.32.4.710 · DOI · Paper page
- Mori, 2000, Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men, Circulation, 102, 1264, 10.1161/01.CIR.102.11.1264 · DOI · Paper page
- Mori, 2004, ω3 Fatty acids and inflammation, Curr Atherosclerosis Rep, 6, 461, 10.1007/s11883-004-0087-5 · DOI · Paper page
- Knapp, 1997, Dietary fatty acids in human thrombosis and hemostasis, Am J Clin Nutr, 65, 1687S, 10.1093/ajcn/65.5.1687S · DOI · Paper page
- Dunstan, 1999, A randomised, controlled study of the effects of aerobic exercise and dietary fish on coagulation and fibrinolytic factors in type 2 diabetics, Thromb Haemostasis, 81, 367, 10.1055/s-0037-1614479 · DOI
- Calder, 2001, Polyunsaturated fatty acids, inflammation, and immunity, Lipids, 36, 1007, 10.1007/s11745-001-0812-7 · DOI · Paper page
- Mori, 1997, Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease, Arterioscler Thromb Vasc Biol, 17, 279, 10.1161/01.ATV.17.2.279 · DOI · Paper page
- Mori, 2004, The effect of fish and fish oil-derived omega-3 fatty acids on lipid oxidation, Redox Report, 9, 193, 10.1179/135100004225005200 · DOI
- Bang, 1971, Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos, Lancet, 1, 1143, 10.1016/S0140-6736(71)91658-8 · DOI · Paper page
- Woodman, 2003, Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrilolytic and vascular function in Type 2 diabetic patients, Atherosclerosis, 166, 85, 10.1016/S0021-9150(02)00307-6 · DOI · Paper page
- Nestel, 2002, The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans, Am J Clin Nutr, 76, 326, 10.1093/ajcn/76.2.326 · DOI · Paper page
- Park, 2002, EPA, but not DHA, decreases mean platelet volume in normal subjects, Lipids, 37, 941, 10.1007/s11745-006-0984-1 · DOI
- Mori, 1999, Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans, Hypertension, 34, 253, 10.1161/01.HYP.34.2.253 · DOI · Paper page
- Halvorsen, 1997, The effect of highly purified eicosapentaenoic and docosahexaenoic acids on monocyte phagocytosis in man, Lipids, 32, 935, 10.1007/s11745-997-0120-2 · DOI
- Grimsgaard, 1998, Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans, Am J Clin Nutr, 68, 52, 10.1093/ajcn/68.1.52 · DOI · Paper page
- Yamamoto, 1995, Improvement of coronary vasomotion with eicosapentaenoic acid does not inhibit acetylcholine-induced coronary vasospasm in patients with variant angina, Jap Circ J, 59, 608, 10.1253/jcj.59.608 · DOI
- Agren, 1997, Hemostatic factors and platelet aggregation after a fish-enriched diet or fish oil or docosahexaenoic acid supplementation, Prostagland Leuk Essent Fatty Acids, 57, 419, 10.1016/S0952-3278(97)90421-X · DOI
- Agren, 1996, Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels, Eur J Clin Nutr, 50, 765
- Hamazaki, 1996, Docosahexaenoic acid-rich fish oil does not affect serum lipid concentrations of normolipidemic young adults, J Nutr, 126, 2784
- Hirai, 1989, Effect of oral administration of highly purified eicosapentaenoic acid and docosahexaenoic acid on platelet function and serum lipids in hyperlipidemic patients, Adv Prost Thromb Leuk Res, 19, 627
- Hirai, 1987, Effect of supplementation of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemostatic function in healthy subjects, Adv Prost Thromb Leuk Res, 17B, 838
- von Schacky, 1985, Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans, J Clin Invest, 76, 2446, 10.1172/JCI112261 · DOI · Paper page
- Saito, 1999, An assessment of appropriate vitamin E content in fish oil capsules as estimated by lipid peroxide and vitamin E levels in human blood, J Clin Biochem Nutr, 26, 35, 10.3164/jcbn.26.35 · DOI
- Tagawa, 1999, Long-term treatment with eicosapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilatation in patients with coronary artery disease, J Cardiovasc Pharm, 33, 633, 10.1097/00005344-199904000-00017 · DOI
- Nakamura, 1998, Effects of eicosapentaenoic acids on remnant-like particles, cholesterol concentrations and plasma fatty acid composition in patients with diabetes mellitus, In Vivo, 12, 311
- Harris, 1997, n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans, Am J Clin Nutr, 65, 459, 10.1093/ajcn/65.2.459 · DOI
- Nishikawa, 1997, Effects of eicosapentaenoic acid (EPA) on prostacyclin production in diabetics: GC/MS analysis of PGI2 and PGI3 levels, Method Find Exp Clin, 19, 429
- Shinozaki, 1996, The long-term effect of eicosapentaenoic acid on serum levels of lipoprotein (a) and lipids in patients with vascular disease, J Atherosclerosis Thromb, 2, 107, 10.5551/jat1994.2.107 · DOI
- Tsuruta, 1996, Effect of purified eicosapentaenoate ethyl ester on fibrinolytic capacity in patients with stable coronary artery disease and lower extremity ischaemia, Coronary Artery Dis, 7, 837, 10.1097/00019501-199611000-00008 · doi:10.1097/00019501-199611000-00008
- Miwa, 1996, Thin-layer chromatography and high-performance liquid chromatography for the assay of fatty acid compositions of individual phospholipids in platelets from non-insulin-dependent diabetes mellitus patients: effect of eicosapentaenoic acid ethyl ester administration, J Chromatogr B, 677, 217, 10.1016/0378-4347(95)00445-9 · doi:10.1016/0378-4347(95)00445-9
- Shimizu, 1995, Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients, Diab Res Clin Prac, 28, 35, 10.1016/0168-8227(95)01056-J · DOI
- Saga, 1994, Changes in platelet count and mean volume of platelet after administration of icosapentaenoic acid ethyl-ester, and factors that may affect those changes, Jpn J Geriatrics, 31, 538, 10.3143/geriatrics.31.538 · doi:10.3143/geriatrics.31.538
- Westerveld, 1993, Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM, Diabetes Care, 16, 683, 10.2337/diacare.16.5.683 · DOI
- Nozaki, 1992, Effects of purified eicosapentaenoic acid ethyl ester on plasma lipoproteins in primary hypercholesterolemia, Int J Vitam Nutr Res, 62, 256
- Wojenski, 1991, Eicosapentaenoic acid ethyl ester as an antithrombotic agent: comparison to an extract of fish oil, Biochim Biophys Acta, 1081, 33, 10.1016/0005-2760(91)90246-E · DOI
- Croset, 1990, Functions and tocopherol content of blood platelets from elderly people after low intake of purified eicosapentaenoic acid, Thromb Res, 57, 1, 10.1016/0049-3848(90)90190-N · DOI
- Hamazaki, 1990, Reduction in microalbuminuria in diabetics by eicosapentaenoic acid ethyl ester, Lipids, 25, 541, 10.1007/BF02537161 · DOI
- Hawthorne, 1990, High dose eicosapentaenoic acid ethyl ester: effects on lipids and neutrophil leukotriene production in normal volunteers, Br J Clin Pharmacol, 30, 187, 10.1111/j.1365-2125.1990.tb03764.x · DOI
- Kamido, 1988, Lipid composition of platelets from patients with atherosclerosis: effect of purified eicosapentaenoic acid ethyl ester administration, Lipids, 23, 917, 10.1007/BF02536337 · DOI
- Tamura, 1987, Anti-thrombotic and anti-atherogenic action of eicosapentaenoic acid, Jpn Circ J, 51, 471, 10.1253/jcj.51.471 · doi:10.1253/jcj.51.471
- Lands, 1985, Relationship of thromboxane generation to the aggregation of platelets from humans: effects of eicosapentaenoic acid, Prostaglandins, 30, 819, 10.1016/0090-6980(85)90010-3 · doi:10.1016/0090-6980(85)90010-3
- Tamura, 1985, Effects of eicosapentaenoic acid on hemostatic function and serum lipids in humans, Adv Prost Thromb Leuk Res, 15, 265
- Nagakawa, 1983, Effect of eicosapentaenoic acid on the platelet aggregation and composition of fatty acid in man. A double blind study, Atherosclerosis, 47, 71, 10.1016/0021-9150(83)90073-4 · DOI
- Terano, 1983, Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects, Atherosclerosis, 46, 321, 10.1016/0021-9150(83)90181-8 · DOI · Paper page
- Ferretti, 1998, Dietary docosahexaenoic acid reduces the thromboxane/prostacyclin synthetic ratio in humans, J Nutr Biochem, 9, 88, 10.1016/S0955-2863(97)00172-1 · DOI
- Conquer, 1997, Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores, Lipids, 32, 341, 10.1007/s11745-997-0043-y · DOI
- Nelson, 1997, The effect of dietary docosahexaenoic acid on plasma lipoproteins and tissue fatty acid composition in humans, Lipids, 32, 1137, 10.1007/s11745-997-0146-5 · DOI
- Nelson, 1997, The effect of dietary docosahexaenoic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans, Lipids, 32, 1129, 10.1007/s11745-997-0145-6 · DOI
- Kobayashi, 1987, Changes of hemorrheological properties by highly purified DHA in normal subjects, Adv Prost Thromb Leuk Res, 17B, 866
- Hulthe, 2000, The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study, Arterioscler Thromb Vasc Biol, 20, 2140, 10.1161/01.ATV.20.9.2140 · DOI · Paper page
- Lahdenpera, 1996, Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides, Diabetologia, 39, 453, 10.1007/BF00400677 · DOI
- Morris, 1993, Does fish oil lower blood pressure: a meta-analysis of controlled trials, Circulation, 88, 523, 10.1161/01.CIR.88.2.523 · DOI · Paper page
- Mclennan, 1996, The cardiovascular protective role of docosahexaenoic acid, Eur J Pharmacol, 300, 83, 10.1016/0014-2999(95)00861-6 · DOI · Paper page
- Mori, 1992, Differential effect of aspirin on platelet aggregation in IDDM, Diabetes, 41, 261, 10.2337/diab.41.3.261 · DOI
- Akiba, 2000, Involvement of lipoxygenase pathway in docosapentaenoic acid-induced inhibition of platelet aggregation, Biol Pharm Bull, 23, 1293, 10.1248/bpb.23.1293 · DOI
- Swann, 1990, Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function, J Biol Chem, 265, 21692, 10.1016/S0021-9258(18)45795-X · DOI
- Abeywardena, 1991, Differential effects of dietary fish oil on myocardial prostaglandin I2 and thromboxane A2 production, Am J Physiol Heart Circ Physiol, 260, H379, 10.1152/ajpheart.1991.260.2.H379 · DOI
- Mori, 1999, Fish oils: dyslipidaemia and glycaemic control in diabetes, Prac Diab Int, 16, 223, 10.1002/pdi.1960160712 · DOI
- Berge, 1999, In contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation, Biochem J, 343, 191, 10.1042/bj3430191 · DOI
- Pineda, 1999, Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging., Curr Opin Lipidol, 10, 151, 10.1097/00041433-199904000-00009 · DOI · Paper page
- Randle, 1998, Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years, Diabetes Metab Rev, 14, 263, 10.1002/(SICI)1099-0895(199812)14:4<263::AID-DMR233>3.0.CO;2-C · doi:10.1002/(sici)1099-0895(199812)14:4<263::aid-dmr233>3.0.co;2-c
- Malasanos, 1991, Biological effects of omega-3 fatty acids in diabetes mellitus, Diabetes Care, 14, 1160, 10.2337/diacare.14.12.1160 · DOI
- De Caterina, 2000, Fatty acid modulation of endothelial activation, Am J Clin Nutr, 71, 213S, 10.1093/ajcn/71.1.213S · DOI · Paper page
- Mori, 2000, Effect of ω3 fatty acids on oxidative stress in humans: GCMS measurement of urinary F2-isoprostane excretion, Redox Report, 5, 45, 10.1179/rer.2000.5.1.45 · DOI · Paper page
Cited by
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
Lavie, C. J., Milani, R. V., Mehra, M. R., & Ventura, H. O. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.084 · Cited by 644
“doses of DHA than with similar doses of EPA (78).”
Backgroundn–3 Fatty Acids in Cardiovascular Disease
De Caterina, R. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1008153 · Cited by 568
Cardiovascular effects of marine omega-3 fatty acids
Saravanan, P., Davidson, N. C., Schmidt, E. B., & Calder, P. C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60445-x · Cited by 511
The lipid biochemistry of eukaryotic algae
Li-Beisson, Y., Thelen, J. J., Fedosejevs, E., & Harwood, J. L. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2019.01.003 · Cited by 453
Metadata
- Authors
- Mori, T. A., & Woodman, R. J.
- Venue
- Current Opinion in Clinical Nutrition & Metabolic Care
- Published
- 2006-03
- Volume
- 9
- Issue
- 2
- Pages
- 95-104
- ISSN
- 1363-1950 (ISSN-L)
- OpenAlex
- W2007259227
- Cited by
- 226
- References
- 19
- FWCI
- 13.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. https://app.cochat.ai/papers/10.1097/01.mco.0000214566.67439.58
- The paper
- Mori, T. A., & Woodman, R. J. (2006). The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Current Opinion in Clinical Nutrition & Metabolic Care. https://doi.org/10.1097/01.mco.0000214566.67439.58
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.